# Beijing VJTBio Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-vjtbio-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.vjtbio.com
- Total disclosed funding: $15M
- Latest round: Series C (May 22, 2023)
- Investors on record: 10

## About

Based in Beijing, China, and established in 2016, Beijing VJTBio Co., LTD. is a biotechnology company that engages in the R&D, production, and sales of new drugs for animals. It has a production base in Zhejiang, established in 2020, covering 30 mu, and equipped with two production factories. Dr Haoshu Luo, the company's president, engaged in the R&D of reproductive diseases and genetic engineering drugs and published more than 30 SCI papers. In May 2023, Beijing VJTBio Co., LTD. raised series C funding led by new investor China Life Private Equity Investment Company Limited, with participation from other new investors Shanghai Industrial Intellectual Property Operation Investment Management, Xinshang Investment, Zhongguancun Science City Capital, and returning investors FC Capital - China, Kecan Capital, SDIC Venture Capital.

Beijing VJTBio Co., LTD. provides biological drugs for animal reproduction, pet diseases, and disease prevention and control. It established animal cell drug-expression technology platforms. It developed recombinant long-acting porcine follicle-stimulating hormone for pigs cattle, and sheep breeding. And it developed cytokine and subunit vaccine products for PEDV-induced diarrhoea in piglets. And it also provides a set of drug pilot production, quality control, and registration application industrial systems.

## Funding rounds

- Series C, May 22, 2023 — SDIC Venture Capital, China Life Capital, Shanghai Industrial Intellectual Property Operation Investment Management, FC Capital - China, Kecan Capital, Zhongguancun Science City Capital, Xinshang Investment
- Series B, Nov 2, 2020, $15M — Beijing Capital Science and Technology Development Group Investment Management, SDIC Venture Capital, FC Capital - China
- Series A, Sep 17, 2019 — Dexin Venture, Junyue Capital

## Investors

- Dexin Venture — Series A
- Junyue Capital (https://capitalatlas.ai/funds/junyue-capital) — Series A
- Beijing Capital Science and Technology Development Group Investment Management (https://capitalatlas.ai/funds/beijing-capital-science-and-technology-development-group-inv) — Series B
- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series B, Series C
- FC Capital - China (https://capitalatlas.ai/funds/fc-capital-china) — Series B, Series C
- China Life Capital — Series C
- Shanghai Industrial Intellectual Property Operation Investment Management — Series C
- Kecan Capital (https://capitalatlas.ai/funds/kecan-capital) — Series C
- Zhongguancun Science City Capital (https://capitalatlas.ai/funds/zhongguancun-science-city-capital) — Series C
- Xinshang Investment (https://capitalatlas.ai/funds/xinshang-investment) — Series C